Apollo Medical Holdings Inc
F:3AM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Apollo Medical Holdings Inc
F:3AM
|
US |
|
ADTRAN Holdings Inc
F:QH9
|
US |
|
Chewy Inc
F:3HH
|
US |
Apollo Medical Holdings Inc
Apollo Medical Holdings, also known as ApolloMed, is a physician-led healthcare company that helps manage patient care for health plans, hospitals, and other risk-bearing medical groups. It works through affiliated doctors and care teams that handle primary care, hospital visits, specialist coordination, and post-acute care for patients who need closely managed treatment. The company makes money mainly by taking on contracts where it is paid to manage the medical needs of a patient group rather than just billing for each visit. It also earns fees for medical management and related services. In simple terms, ApolloMed sits between insurers and doctors, helping organize care, reduce fragmented treatment, and keep patients moving through the system smoothly. What makes its business different is that it combines doctor groups, care management, and risk-bearing contracts under one model. That gives it a direct role in how care is delivered, especially for patients with complex or ongoing needs, and makes it more of a healthcare operator than a traditional hospital or insurance company.
Apollo Medical Holdings, also known as ApolloMed, is a physician-led healthcare company that helps manage patient care for health plans, hospitals, and other risk-bearing medical groups. It works through affiliated doctors and care teams that handle primary care, hospital visits, specialist coordination, and post-acute care for patients who need closely managed treatment.
The company makes money mainly by taking on contracts where it is paid to manage the medical needs of a patient group rather than just billing for each visit. It also earns fees for medical management and related services. In simple terms, ApolloMed sits between insurers and doctors, helping organize care, reduce fragmented treatment, and keep patients moving through the system smoothly.
What makes its business different is that it combines doctor groups, care management, and risk-bearing contracts under one model. That gives it a direct role in how care is delivered, especially for patients with complex or ongoing needs, and makes it more of a healthcare operator than a traditional hospital or insurance company.
Strong start: Astrana reported first-quarter revenue of $965.1 million, up 56% year over year, and adjusted EBITDA of $66.3 million, up 82%, both at the high end of guidance.
Full-risk ramp: Management said the company moved ahead on full-risk contract conversions, with about 40% of owned membership and around 80% of care partners' revenue now in full-risk arrangements.
Cost trends: Medical cost performance was better than expected across both legacy Astrana and Prospect, with the company saying its 2026 blended cost trend assumption of approximately 5.2% still looks conservative.
Deleveraging: Net leverage fell to approximately 2.3x pro forma trailing 12 months, ahead of plan, and management said it expects to end 2026 at or below 2x.
AI leverage: Management highlighted AI-driven workflow automation as a key source of operating leverage, including lower G&A, faster claims processing, and better care management.
Guidance held: Full-year 2026 guidance was reaffirmed for revenue of $3.8 billion to $4.1 billion, adjusted EBITDA of $250 million to $280 million, and free cash flow of $105 million to $132.5 million.
Prospect on track: The Prospect integration remained on track, gross provider retention stayed above 99%, and management said it is tracking toward the high end of the $12 million to $15 million synergy target.
